Janet Brutschea Haugen - 30 Sep 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Director
Signature
/s/ Louis Lalli, as an agent for Janet Haugen
Issuer symbol
WST
Transactions as of
30 Sep 2025
Net transactions value
+$12,592
Form type
4
Filing time
02 Oct 2025, 12:56:31 UTC
Previous filing
02 Jul 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAUGEN JANET BRUTSCHEA Director 530 HERMAN O. WEST DRIVE, EXTON /s/ Louis Lalli, as an agent for Janet Haugen 02 Oct 2025 0001185136

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WST Common Stock 1,319 30 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Phantom Stock Unit Award $12,592 +48 +42% $262.33 162 30 Sep 2025 Common Stock 48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 1,071 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
F2 Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.